0700 10992 Book a consultation

Assisted Oocyte Activation

Assisted oocyte activation is a laboratory step performed after ICSI that supports the initiation of fertilisation when the natural signal between the sperm and the oocyte is insufficient.

The procedure is performed on mature oocytes in the embryology laboratory and does not require any additional intervention, anaesthesia or recovery for the patient.

At Adella Clinic, we discuss this option after a careful review of previous treatment, when fertilisation has not occurred following ICSI or when only a very small number of oocytes have fertilised.

Duration

Assisted oocyte activation is performed in the laboratory shortly after the sperm has been injected into the oocyte using ICSI.

Stay at the Clinic

The procedure does not require any additional stay at the clinic beyond the other stages of IVF treatment.

Feeling

No additional medication, anaesthesia or recovery is required for the patient.

Additional Signal to Initiate Fertilisation

When does fertilisation need support?

How does the natural process occur?

  • During ICSI, the embryologist injects a selected sperm cell directly into a mature oocyte.
  • Biological processes must then take place between the two cells to initiate fertilisation.
  • One of the most important of these is the calcium signal that activates the oocyte.

What can interfere with this process?

  • The enzyme PLCζ, which is contained in the sperm cell, plays a key role in generating the calcium signal.
  • Sometimes, the signal is insufficient due to factors related to the sperm, the oocyte or the interaction between them.
  • In such cases, ICSI may have been performed correctly, but fertilisation may not proceed.

Individual Assessment Following Analysis of Previous Cycles

When might we discuss the procedure?

  • 1

    Following complete fertilisation failure

    A key indication is a previous ICSI cycle in which none of the mature injected oocytes fertilised normally.
    Rather than automatically repeating the same approach, we analyse what happened and assess whether activation could help address the specific problem.
  • 2

    When the fertilisation rate is very low

    The procedure may be discussed when fewer than 30% of the mature oocytes fertilised following ICSI.
    This percentage is a guide. The decision also depends on the number of oocytes and the overall embryological picture.
  • 3

    In cases of globozoospermia

    Globozoospermia is a rare condition in which the sperm cells have round heads and an absent or severely impaired acrosome.
    The condition is often associated with insufficient PLCζ and the absence of the signal required to activate the oocyte.
  • 4

    When there is evidence of impaired activation

    Sometimes, the results of a previous cycle indicate a problem with activation even when globozoospermia has not been identified.
    In these cases, we consider factors related to the oocyte, the sperm and the interaction between them together
What is assisted oocyte activation?
Assisted oocyte activation, also known as AOA, supports the calcium signal required to initiate fertilisation.
Following ICSI, mature oocytes are placed briefly in a specialised activation medium, which induces a temporary increase in calcium.
They are then carefully washed and returned to the incubator, where their development continues under controlled conditions.
What does the procedure not do?
Assisted oocyte activation does not alter the genetic material of the oocyte or the sperm.
It does not increase ovarian reserve, increase the number of oocytes retrieved or correct chromosomal abnormalities.
The procedure does not mature immature oocytes and should not be confused with “ovarian activation” or follicular activation

The Faces of Hope

Before recommending the procedure, we look for the cause

The number and maturity of the oocytes in the previous cycle, the characteristics and origin of the sperm, how ICSI was performed, and the results of laboratory monitoring.

We also take into account the findings from all previous procedures in order to distinguish an isolated abnormal result from a recurring fertilisation problem.

The aim is for assisted oocyte activation to have a clear purpose and medical rationale within your treatment plan.

What does the procedure mean for you?

Assisted oocyte activation is not a separate medical procedure for the patient.

No additional medication, anaesthesia or special recovery is required. Your involvement remains the same as in the planned ICSI cycle.

Before the procedure, we will discuss why we are recommending it, how it will be performed and how we will assess the outcome.

ICSI, Activation and Fertilisation Monitoring

How is the procedure performed in the laboratory?

What is performed?

  • Following oocyte retrieval, the maturity of the retrieved oocytes is assessed.
  • A selected sperm cell is injected into each suitable mature oocyte using ICSI.
  • The oocytes are placed briefly in an activation medium.
  • After treatment, they are carefully washed and returned to the incubator.

What happens next?

  • The following day, the oocytes are checked to determine whether normal fertilisation has occurred.
  • The main sign is the presence of two pronuclei, referred to as 2PN.
  • They contain the genetic material from the oocyte and the sperm.
  • The fertilised oocytes continue to develop according to the standard laboratory protocol.

Fertilisation, Embryo Development and Realistic Expectations

What outcome can be expected?

The main aim of assisted oocyte activation is to support normal fertilisation of mature oocytes following ICSI.

The clearest benefit is observed in carefully selected patients who experienced complete fertilisation failure or a very low fertilisation rate in a previous cycle.

Once fertilisation has occurred, the development of each embryo depends on the quality of the oocyte and sperm, its genetic characteristics and its individual biological potential.

What are the limitations?

  • The procedure supports only the initial stage of fertilisation following ICSI.
  • It does not guarantee that every oocyte will fertilise normally.
  • It does not guarantee continued embryo development, implantation or pregnancy.
  • It does not improve age-related oocyte quality or correct genetic abnormalities.

How do we ensure safety?

  • The procedure is performed entirely in the embryology laboratory according to a controlled protocol.
  • It does not involve any additional physical burden or intervention for the patient.
  • Available clinical data do not indicate a significant increase in miscarriage or congenital abnormalities compared with ICSI without activation.
  • Due to the more limited long-term data, the method is used only when there are clearly defined medical indications

Frequently Asked Questions

Procedures

News

See all news

Contact form

Contact Us
Address

Sofia, 15g Tintyava Street

Working hours
Follow us